W
Wedbush Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
151 |
151
Edgewise Therapeutics
EWTX
$1.64B
|
LC
Laura Chico
| $15.57 | $43 |
176%
upside
| Outperform | 4 months ago |
|
152 |
152
NovoCure
NVCR
$1.37B
|
DN
David Nierengarten
| $12.28 | $27 |
120%
upside
| Neutral | 4 months ago |
|
153 |
153
Kiniksa Pharmaceuticals
KNSA
$2.65B
|
DN
David Nierengarten
| $35.71 | $34 |
5%
downside
| Outperform | 4 months ago |
|
154 |
SAFE
154
Safehold
SAFE
$1.17B
|
RA
Richard Anderson
| $16.30 | $20 |
23%
upside
| Neutral | 5 months ago |
|
155 |
155
Monro
MNRO
$530M
|
SB
Seth Basham
| $17.68 | $19 |
7%
upside
| Outperform | 5 months ago |
|
156 |
156
Dutch Bros
BROS
$8.38B
|
NS
Nick Setyan
| $65.98 | $90 |
36%
upside
| Outperform | 5 months ago |
|
157 |
157
Protagonist Therapeutics
PTGX
$3.77B
|
YZ
Yun Zhong
| $60.53 | $70 |
16%
upside
| Outperform | 5 months ago |
|
158 |
158
Texas Roadhouse
TXRH
$11.2B
|
NS
Nick Setyan
| $168.85 | $210 |
24%
upside
| Outperform | 5 months ago |
|
159 |
159
Petco
WOOF
$1.03B
|
SB
Seth Basham
| $3.67 | $4 |
9%
upside
| Outperform | 5 months ago |
|
160 |
160
Chewy
CHWY
$17.5B
|
SB
Seth Basham
| $42.33 | $39 |
8%
downside
| Outperform | 5 months ago |
|
161 |
161
Huron Consulting
HURN
$2.44B
|
DI
Daniel Ives
| $141.27 | $165 |
17%
upside
| Outperform | 5 months ago |
|
162 |
162
Rumble
RUM
$2.41B
|
SD
Scott Devitt
| $7.11 | $10 |
41%
upside
| Neutral | 5 months ago |
|
163 |
163
RH
RH
$4.7B
|
SB
Seth Basham
| $251 | $350 |
39%
upside
| Outperform | 5 months ago |
|
164 |
164
KB Home
KBH
$4.63B
|
JM
Jay McCanless
| $67.97 | $75 |
10%
upside
| Neutral | 5 months ago |
|
165 |
SNDK
165
Sandisk Corporation Common Stock
SNDK
$9.99B
|
MB
Matt Bryson
| $68.55 | $80 |
17%
upside
| Outperform | 5 months ago |
|
166 |
166
Academy Sports + Outdoors
ASO
$3.39B
|
SB
Seth Basham
| $50.86 | $60 |
18%
upside
| Outperform | 5 months ago |
|
167 |
167
Lennar Class A
LEN
$36.7B
|
JM
Jay McCanless
| $141.88 | $158 |
11%
upside
| Neutral | 5 months ago |
|
168 |
168
Monte Rosa Therapeutics
GLUE
$305M
|
RD
Robert Driscoll
| $4.94 | $17 |
244%
upside
| Outperform | 5 months ago |
|
169 |
169
Darden Restaurants
DRI
$24.5B
|
NS
Nick Setyan
| $210.14 | $235 |
12%
upside
| Outperform | 5 months ago |
|
170 |
170
Williams-Sonoma
WSM
$24.7B
|
SB
Seth Basham
| $202.42 | $170 |
16%
downside
| Neutral | 5 months ago |
|
171 |
171
Immunome
IMNM
$916M
|
DN
David Nierengarten
| $10.52 | $33 |
214%
upside
| Outperform | 5 months ago |
|
172 |
ZBIO
172
Zenas BioPharma, Inc. Common Stock
ZBIO
$864M
|
MF
Martin Fan
| $20.51 | $35 |
71%
upside
| Outperform | 5 months ago |
|
173 |
173
Getty Images
GETY
$772M
|
MP
Michael Pachter
| $1.86 | $7.70 |
314%
upside
| Outperform | 5 months ago |
|
174 |
174
National Health Investors
NHI
$3.72B
|
RA
Richard Anderson
| $78.40 | $88 |
12%
upside
| Outperform | 5 months ago |
|
175 |
175
Tourmaline Bio
TRML
$687M
|
LC
Laura Chico
| $26.74 | $43 |
61%
upside
| Outperform | 5 months ago |
|